RPSAP14

Across TCGA pan-cancer cohorts, RPSAP14 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated RPSAP14 data layer compared with 2 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPSAP14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPSAP14 expression acts as an unfavorable survival marker, although some lineages such as GBM and UVM show a favorable association.

KIRC, OV, and GBM are the cancer types where RPSAP14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.827	0.915	<.001	80	view →
OV	OS	Tertile	All	0.312	0.410	.010	44	view →
GBM	OS	Median	All	0.518	0.316	<.001	42	view →
ACC	OS	Quartile	III,IV	0.187	0.833	.006	36	view →
UCEC	DFS	Median	All	0.788	0.880	.002	30	view →
KIRP	DFS	Median	All	0.589	0.666	.008	29	view →
UVM	DFS	Quartile	All	0.844	0.449	.013	25	view →
STAD	DFS	Median	IV	0.121	0.669	.002	22	view →
LAML	DFS	Median	All	0.696	0.451	.014	20	view →
UCS	OS	Tertile	IV	0.922	0.253	.024	18	view →
COAD	OS	Quartile	IV	0.867	0.257	.012	15	view →
READ	OS	Tertile	IV	0.850	0.352	.004	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 28 lineages.

RPSAP14–KIRC (DFS)

Open the KIRC breakdown →